16-30 of 732
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of SchizophreniaDigital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
Shifting the Script: How Inner Dialogue Influences Psoriasis Progress
On the Frontlines of PsoriasisShifting the Script: How Inner Dialogue Influences Psoriasis Progress
Ryan Quigley
Michael Greenberg, MD
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
NeuroFrontiersRethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Charles Turck, PharmD, BCPS, BCCCP
Desiree Matthews, PMHNP-BC
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Project Oncology®Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Victoria Coleman-Cowger, PhD
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiersBridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Shelina Ramnarine, PhD
Michelle Scargle, MD
Margaret Emerson, DNP, APRN, PMHNP-BC
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Brian P. McDonough, MD, FAAFP
Ahmed Makhlouf, MD
- advertisement
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiersAdvancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Charles Turck, PharmD, BCPS, BCCCP
Ragy R. Girgis, MD, MS
Desiree Matthews, PMHNP-BC
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiersUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
Jeffrey A. Lieberman, MD
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiersHarnessing AI to Predict and Prevent Schizophrenia Relapse
Matcheri S. Keshavan, MD
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiersEngaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
Shelina Ramnarine, PhD
Apurva Bhatt, MD
Shannon Pagdon, BA
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiersApplying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Charles Turck, PharmD, BCPS, BCCCP
David Kimhy, PhD
Aducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
NeuroFrontiersAducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
Ryan Quigley
- advertisement
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Project Oncology®Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Understanding and Treating Trauma in Pediatric Patients: Key Management Strategies
Clinician's RoundtableUnderstanding and Treating Trauma in Pediatric Patients: Key Management Strategies
Ryan Quigley
Heather Forkey, MD
Wynne Morgan, MD
